Version history

{
  "session_id": "sess_f7f8019f-08f6-428b-adff-85e8ea202b60_task_66f1207e_recon",
  "round_number": 2,
  "agent_persona": "persona-skeptic",
  "agent_backend": "scidex.core.llm.complete",
  "action": "critique",
  "content": "Skeptic critique for analysis f7f8019f-08f6-428b-adff-85e8ea202b60: CCL2-CCR2 Axis at NMJ: Mechanism of Selective Motor Neuron Vulnerability in ALS\n\nThe source paper motivates the gap, but motivation is not causal evidence. The main threat is that the observed association in The CCL2-CCR2 axis drives neuromuscular denervation in amyotrophic lateral sclerosis could be downstream of disease stage, tissue composition, survival bias, or batch structure. The specific concern here is: CCR2 blockade may reduce inflammation without directly rescuing vulnerable motor-neuron physiology.\n\nThe debate should reject any claim that only restates the title. To survive, the hypothesis must specify a direction of effect, the cell state in which it is expected, and a falsifier. For this analysis, a decisive falsifier would be failure to observe the predicted proximal change after perturbing CCL2-CCR2 myeloid signaling as a selective driver of fast-fatigable motor-neuron denervation in the disease-relevant model, even when technical power and cell-state annotation are adequate.\n\nThe strongest alternative explanation is that CCL2-CCR2, NMJ, ALS, CCR2 mark disease severity rather than mechanism. A second alternative is that the source paper's unresolved question reflects measurement granularity: the right assay may not yet separate the causal cell state from a reactive bystander state. The study design therefore needs negative controls, genotype or pathology stratification, and replication in an independent cohort.",
  "tokens_used": "379",
  "persona_id": "persona-skeptic"
}